Synamics Therapeutics
PrivateLast Round
Pre Seed
Jul 16, 2024
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synamics Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Pre Seed round in July 2024.
Synamics Therapeutics is a biotechnology company that leverages artificial intelligence and predictive modeling to develop adaptive cancer therapies aimed at overcoming drug resistance.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synamics Therapeutics Comparables
Compare Synamics Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResistanceBio | 79% | |
| Charm Therapeutics | 78% | |
| Iambic Therapeutics | 77% |
For institutional investors. Book with your work email.
Synamics Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 865% MoM, reaching 1.4K.
- May 1, 2025
Monthly visitors increased 302% MoM.
For institutional investors. Book with your work email.
Synamics Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synamics Therapeutics's valuation, stock price, and market status.
Is Synamics Therapeutics a public or private company?
Synamics Therapeutics is a private company.
What is the current stock price of Synamics Therapeutics?
Synamics Therapeutics is a private company, so its shares have no public market price. Caplight tracks Synamics Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synamics Therapeutics worth (valuation)?
Valuation information for Synamics Therapeutics is not publicly available.
Can I buy Synamics Therapeutics stock?
Synamics Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synamics Therapeutics's last funding round?
Synamics Therapeutics's most recent funding round was Pre Seed on July 16, 2024.
Who are the main investors in Synamics Therapeutics?
Investor information for Synamics Therapeutics is not publicly disclosed.
Will Synamics Therapeutics IPO soon?
No public IPO plans have been announced for Synamics Therapeutics.
How can I track Synamics Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Synamics Therapeutics's shares on secondary markets.